Sleep disorder may be marker for neurodegenerative diseases: researchers - Action News
Home WebMail Saturday, November 23, 2024, 10:45 AM | Calgary | -12.0°C | Regions Advertise Login | Our platform is in maintenance mode. Some URLs may not be available. |
Science

Sleep disorder may be marker for neurodegenerative diseases: researchers

Individuals with a deep-sleep disorder are more likely to develop neurodegenerative diseases such as Parkinson's or dementia, a new Canadian study reports.

Individuals with a deep-sleep disorder are more likely to develop neurodegenerative diseases such as Parkinson's or dementia, a new Canadian study reports.

Thestudy, by Dr. Ronald Postuma from the Research Institute of the McGill University Health Centre and Dr. Jacques Montplaisir from the University of Montreal, suggests 52.4 per cent of patients with rapid eye movement (REM) sleep disorderwill develop aneurodegenerative disease within 12 yearsof the initial diagnosis.

The researchers followed all thesleep-disorder patients at Montreal's Hpital du Sacr Coeur who had beendiagnosed with the disorder.

Of93 patients studied, 26 developed a neurodegenerative disorder, including:

  • Fourteen with Parkinson's.
  • Seven with Lewy body dementia, a common cause of dementia among the elderly.
  • Four withclinical dementia.
  • One with multiple system atrophy, which affects movement, blood pressure and other body functions.

"The estimated five-year risk of neurodegenerative disease was 17.7 per cent, the10-year risk was 40.6 per cent and the12-year risk was 52.4," the reseatchers said in an abstract of their paper published online.

"These results establish a clear link and indicate that these sleep disorders could be a predictor of neurodegenerative disease," Postuma said in a news release.

The participants averaged65.4 years old, andfour out of five were men.

During REM sleep, also known as the dream stage of sleep, the muscles don't relax, as happens normally. Instead, those with the disordermay punch, kick and cry out.

Preliminary U.S. estimates suggest one of every 200 people may suffer from the disorder.

Postuma said the study involved only people with no known cause for the problem.

The study,supported by grants from the Canadian Institutes of Health Research and the Fonds de la recherche en sant du Qubecwas publishedWednesday in Neurology,thejournal of the American Academy of Neurology.